3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
18
Breast Neoplasms
12
Neoplasm Metastasis
3
Neoplasms by Site
2
Neoplasms
2
Breast Diseases
2
Sleep Wake Disorders
1
Skin Diseases
1
Salivary Gland Adenoma, Pleomorphic
1
Osteoporosis
1
Leiomyoma
1
Hemorrhage
1
Fatigue
1
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
1
Breast Neoplasms, Male
1
Advanced Breast Cancer
1
Interventions
binimetinib
2
Aminolevulinic Acid
2
palbociclib
1
ipatasertib
1
encorafenib
1
atezolizumab
1
Vemurafenib
1
Paclitaxel
1
Gonadotropin-Releasing Hormone
1
Docetaxel
1
Dacarbazine
1
Capecitabine
1
Anastrozole
1
AZD9833
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Skin Diseases
×
Gonadotropin-Releasing Hormone
×
Clear all
NCT04711252
2025-10-14
SERENA-4
AstraZeneca
Phase 3
Active not recruiting
1,370 enrolled